CO(2) Laser therapy versus cryotherapy in treatment of genital warts; a Randomized Controlled Trial (RCT)
,
Abstract
Background and Objective: Genital warts, due to specific types of the human papillomavirus, have long been regarded as one of the most important causes of cervical cancer and one of the most common cause of Sexually Transmited Diseases (STDs). Over the years, it has been the focus of several studies in order to find the best effective approach to eradicate the virus, however there are still controversies regarding this matter. We compared efficacy of the two physical ablative therapies; Liquid Nitrogen and CO laser.
Material and Methods: One hundred and sixty patients, with external genital warts, were divided into two groups. Each group consisted of 80 patients treated with CO -laser or cryotherapy. Clearance and recurrence rates were evaluated for 3months.
Results: Complete clearance was achieved in 76 lesions (95%) treated by CO -laser and 37 lesions (46.2%) treated by cryotherapy which was significantly different (p < 0.001). In the CO -laser group, lesions required only one treatment to clear while in the cryotherapy group, lesions required two (12%) even up to three (12.2%) treatments for some patients to clear completely. Laser therapy was associated with less recurrence rate compared to cryotherapy (0.05% Vs 0.18%).
Conclusion: Generally, the efficacy of CO laser treatment of external genital warts was approximately two fold greater than cryotherapy and it was associated with lower recurrence rate.
Dunne EF, Friedman A, Datta SD, Markowitz LE, Workowski KA. Updates on Human Papillomavirus and Genital Warts and Counseling Messages From the 2010 Sexually Transmitted Diseases Treatment Guidelines.Clin Infect Dis 2011; 53 (suppl 3): S143-S152.
Dillner J, Brown DR.Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine? Expert Rev Mol Med 2004;6: 1-21.
af Geijersstam, V. Eklund C, Wang Z, Sapp M, Schiller JT, Dillner J, Dillner L. A survey of seroprevalences of human papillomavirus types 16, 18 and 33 among children. Int J Cancer 1999; 80: 489-493.
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297: 813-819.
Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV.The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.}
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106-3114.8. Parkin DM, Bray F. Chapter 2: the burden of HPV- related cancers. Vaccine 2006; 24(Suppl 3): S3/11-25.
Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, et al. Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008; 84: 161-166.
Mortensen GL, Larsen HK. The quality of life of patients with genital warts: a qualitative study. BMC Public Health 2010; 10: 113.
Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldan K. Genital warts and cost of care in England. Sex Transm Infect 2011; 87: 464-468.
McClean H, Shann S. A cross-sectional survey of treatment choices for anogenital warts. Int J STD AIDS 2005; 16: 212-216.
Ting PT, Dytoc MT. Therapy of external anogenital warts and molluscum contagiosum: a literature review. Dermatol Ther. 2004; 17: 68-101.
Kumar B, Narang T. Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation. Sex Transm Infect 2011; 87: 432.
Sonnex C, Lacey CJ. The treatment of human papillomavirus lesions of the lower genital tract. Best Pract Res Clin Obstet Gynaecol 2001; 15: 801-816.
Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS 2004; 15: 357-364.
Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J 2006; 12: 5.
Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2010; 59(RR-12): 1-110.
Collet-Villette AM, Gaudy-Marqueste C, Grob JJ, Richard MA. Carbon dioxide laser therapy for anogenital warts in children. Ann Dermatol Venereol 2007; 134:829-832.
Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, et al. External Genital Warts: iagnosis, Treatment, and Prevention. Clin Infect Dis 2002;35(Suppl 2): S210-224.
| Files | ||
| Issue | Vol 4 No 4 (2012) | |
| Section | Articles | |
| Keywords | ||
| CO2 laser Genital warts Human Papillomavirus cryotherapy | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
